Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS). View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04-09

AUTHORS

Noriyuki Okonogi, Takuya Kaminuma, Tomoaki Okimoto, Makoto Shinoto, Naoyoshi Yamamoto, Shigeru Yamada, Kazutoshi Murata, Tatsuya Ohno, Yoshiyuki Shioyama, Hiroshi Tsuji, Takashi Nakano, Tadashi Kamada

ABSTRACT

BACKGROUND: The efficacy of carbon-ion radiotherapy (C-ion RT) for lymph node (LN) oligo-recurrence has only been evaluated in limited single-center studies. We aimed to investigate the benefit of C-ion RT for LN oligo-recurrence in a large multi-center study. METHODS: Patients who received C-ion RT between December 1996 and December 2015 at 4 participating facilities and who met the following eligibility criteria were included: (i) histological or clinical diagnosis of LN recurrence; (ii) controlled primary lesion; (iii) no recurrence other than LN; (iv) LN recurrence involved in a single lymphatic site; and (v) age ≥ 20 years. RESULTS: A total of 323 patients were enrolled. Median follow-up period was 34 months for surviving patients. The most common dose fractionation of C-ion RT was 48.0 Gy (relative biological effectiveness) in 12 fractions. Forty-seven patients had a history of RT at the recurrent site. The 2-year local control (LC) and overall survival (OS) rates after C-ion RT were 85% and 63%, respectively. Only 1 patient developed grade-3 toxicity. Factors such as LN diameter, histology, and history of previous RT did not correlate with LC. Smaller diameters (< 30 mm) and numbers (≤ 3) of LN metastases as well as longer disease-free intervals post-primary therapy (≥ 16 months) were associated with significantly better OS. CONCLUSIONS: C-ion RT for LN oligo-recurrence appeared to be effective and safe. C-ion RT may provide a survival benefit to patients with LN oligo-recurrence, particularly to those with few LN metastases, smaller LN diameters, and longer disease-free intervals. More... »

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10147-019-01440-y

DOI

http://dx.doi.org/10.1007/s10147-019-01440-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113328033

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30968270


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National Institutes for Quantum and Radiological Science and Technology", 
          "id": "https://www.grid.ac/institutes/grid.482503.8", 
          "name": [
            "QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okonogi", 
        "givenName": "Noriyuki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kaminuma", 
        "givenName": "Takuya", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Hyogo Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.413699.0", 
          "name": [
            "Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Okimoto", 
        "givenName": "Tomoaki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ion Beam Therapy Center, SAGA HIMAT Foundation, Saga, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shinoto", 
        "givenName": "Makoto", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes for Quantum and Radiological Science and Technology", 
          "id": "https://www.grid.ac/institutes/grid.482503.8", 
          "name": [
            "QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamamoto", 
        "givenName": "Naoyoshi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes for Quantum and Radiological Science and Technology", 
          "id": "https://www.grid.ac/institutes/grid.482503.8", 
          "name": [
            "QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yamada", 
        "givenName": "Shigeru", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murata", 
        "givenName": "Kazutoshi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ohno", 
        "givenName": "Tatsuya", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Ion Beam Therapy Center, SAGA HIMAT Foundation, Saga, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shioyama", 
        "givenName": "Yoshiyuki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes for Quantum and Radiological Science and Technology", 
          "id": "https://www.grid.ac/institutes/grid.482503.8", 
          "name": [
            "QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tsuji", 
        "givenName": "Hiroshi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Gunma University", 
          "id": "https://www.grid.ac/institutes/grid.256642.1", 
          "name": [
            "Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakano", 
        "givenName": "Takashi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National Institutes for Quantum and Radiological Science and Technology", 
          "id": "https://www.grid.ac/institutes/grid.482503.8", 
          "name": [
            "QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan. kamada.tadashi@qst.go.jp."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kamada", 
        "givenName": "Tadashi", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.04.073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007412870"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12094-015-1383-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011357910", 
          "https://doi.org/10.1007/s12094-015-1383-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3346/jkms.2009.24.3.488", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013182687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3346/jkms.2009.24.3.488", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013182687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyp167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014598057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyp167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014598057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.clgc.2017.01.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016455692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1533034615595945", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016677093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1533034615595945", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016677093"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2011.08.036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017514898"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.7636", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018716375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70510-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020430700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(11)70142-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024474871"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(98)00544-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026074608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1748-717x-8-79", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026147741", 
          "https://doi.org/10.1186/1748-717x-8-79"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/bjs.4370", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027424378"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12094-012-0956-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031392636", 
          "https://doi.org/10.1007/s12094-012-0956-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.11.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033784149"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0b013e3182208e58", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035497536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2011.09.053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038164386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jjco/hyn083", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039973595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2010.05.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042099654"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2008.07.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050008070"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.23058", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050595648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.26611", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052457938"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000160703.75808.7d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052575937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.sla.0000160703.75808.7d", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052575937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0031-9155/60/8/3271", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059031274"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2307/3579446", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1070381843"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/030089161109700110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078389831"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/030089161109700110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078389831"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078520481", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-017-0773-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083399651", 
          "https://doi.org/10.1186/s13014-017-0773-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-017-0773-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083399651", 
          "https://doi.org/10.1186/s13014-017-0773-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jso.24757", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090828743"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.21873/anticanres.11991", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1092116097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2017.12.028", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100240901"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-018-0969-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1101003219", 
          "https://doi.org/10.1186/s13014-018-0969-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04-09", 
    "datePublishedReg": "2019-04-09", 
    "description": "BACKGROUND: The efficacy of carbon-ion radiotherapy (C-ion RT) for lymph node (LN) oligo-recurrence has only been evaluated in limited single-center studies. We aimed to investigate the benefit of C-ion RT for LN oligo-recurrence in a large multi-center study.\nMETHODS: Patients who received C-ion RT between December 1996 and December 2015 at 4 participating facilities and who met the following eligibility criteria were included: (i) histological or clinical diagnosis of LN recurrence; (ii) controlled primary lesion; (iii) no recurrence other than LN; (iv) LN recurrence involved in a single lymphatic site; and (v) age\u2009\u2265\u200920\u00a0years.\nRESULTS: A total of 323 patients were enrolled. Median follow-up period was 34\u00a0months for surviving patients. The most common dose fractionation of C-ion RT was 48.0\u00a0Gy (relative biological effectiveness) in 12 fractions. Forty-seven patients had a history of RT at the recurrent site. The 2-year local control (LC) and overall survival (OS) rates after C-ion RT were 85% and 63%, respectively. Only 1 patient developed grade-3 toxicity. Factors such as LN diameter, histology, and history of previous RT did not correlate with LC. Smaller diameters (<\u200930\u00a0mm) and numbers (\u2264\u20093) of LN metastases as well as longer disease-free intervals post-primary therapy (\u2265\u200916\u00a0months) were associated with significantly better OS.\nCONCLUSIONS: C-ion RT for LN oligo-recurrence appeared to be effective and safe. C-ion RT may provide a survival benefit to patients with LN oligo-recurrence, particularly to those with few LN metastases, smaller LN diameters, and longer disease-free intervals.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10147-019-01440-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1312225", 
        "issn": [
          "1341-9625", 
          "1437-7772"
        ], 
        "name": "International Journal of Clinical Oncology", 
        "type": "Periodical"
      }
    ], 
    "name": "Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).", 
    "productId": [
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10147-019-01440-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113328033"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9616295"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30968270"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10147-019-01440-y", 
      "https://app.dimensions.ai/details/publication/pub.1113328033"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-15T09:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000375_0000000375/records_91438_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s10147-019-01440-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10147-019-01440-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10147-019-01440-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10147-019-01440-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10147-019-01440-y'


 

This table displays all metadata directly associated to this object as RDF triples.

234 TRIPLES      20 PREDICATES      56 URIs      16 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10147-019-01440-y schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nad7a3633cbba47f79f842582ea6aeab0
4 schema:citation sg:pub.10.1007/s12094-012-0956-2
5 sg:pub.10.1007/s12094-015-1383-y
6 sg:pub.10.1186/1748-717x-8-79
7 sg:pub.10.1186/s13014-017-0773-4
8 sg:pub.10.1186/s13014-018-0969-2
9 https://app.dimensions.ai/details/publication/pub.1078520481
10 https://doi.org/10.1002/bjs.4370
11 https://doi.org/10.1002/cncr.26611
12 https://doi.org/10.1002/jso.23058
13 https://doi.org/10.1002/jso.24757
14 https://doi.org/10.1016/j.clgc.2017.01.004
15 https://doi.org/10.1016/j.ijrobp.2008.04.073
16 https://doi.org/10.1016/j.ijrobp.2008.07.020
17 https://doi.org/10.1016/j.ijrobp.2010.05.032
18 https://doi.org/10.1016/j.ijrobp.2010.11.031
19 https://doi.org/10.1016/j.ijrobp.2011.08.036
20 https://doi.org/10.1016/j.ijrobp.2011.09.053
21 https://doi.org/10.1016/j.ygyno.2017.12.028
22 https://doi.org/10.1016/s0360-3016(98)00544-6
23 https://doi.org/10.1016/s0959-8049(11)70142-3
24 https://doi.org/10.1016/s1470-2045(12)70510-7
25 https://doi.org/10.1088/0031-9155/60/8/3271
26 https://doi.org/10.1093/jjco/hyn083
27 https://doi.org/10.1093/jjco/hyp167
28 https://doi.org/10.1097/01.sla.0000160703.75808.7d
29 https://doi.org/10.1097/jto.0b013e3182208e58
30 https://doi.org/10.1177/030089161109700110
31 https://doi.org/10.1177/1533034615595945
32 https://doi.org/10.18632/oncotarget.7636
33 https://doi.org/10.21873/anticanres.11991
34 https://doi.org/10.2307/3579446
35 https://doi.org/10.3346/jkms.2009.24.3.488
36 schema:datePublished 2019-04-09
37 schema:datePublishedReg 2019-04-09
38 schema:description BACKGROUND: The efficacy of carbon-ion radiotherapy (C-ion RT) for lymph node (LN) oligo-recurrence has only been evaluated in limited single-center studies. We aimed to investigate the benefit of C-ion RT for LN oligo-recurrence in a large multi-center study. METHODS: Patients who received C-ion RT between December 1996 and December 2015 at 4 participating facilities and who met the following eligibility criteria were included: (i) histological or clinical diagnosis of LN recurrence; (ii) controlled primary lesion; (iii) no recurrence other than LN; (iv) LN recurrence involved in a single lymphatic site; and (v) age ≥ 20 years. RESULTS: A total of 323 patients were enrolled. Median follow-up period was 34 months for surviving patients. The most common dose fractionation of C-ion RT was 48.0 Gy (relative biological effectiveness) in 12 fractions. Forty-seven patients had a history of RT at the recurrent site. The 2-year local control (LC) and overall survival (OS) rates after C-ion RT were 85% and 63%, respectively. Only 1 patient developed grade-3 toxicity. Factors such as LN diameter, histology, and history of previous RT did not correlate with LC. Smaller diameters (< 30 mm) and numbers (≤ 3) of LN metastases as well as longer disease-free intervals post-primary therapy (≥ 16 months) were associated with significantly better OS. CONCLUSIONS: C-ion RT for LN oligo-recurrence appeared to be effective and safe. C-ion RT may provide a survival benefit to patients with LN oligo-recurrence, particularly to those with few LN metastases, smaller LN diameters, and longer disease-free intervals.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree false
42 schema:isPartOf sg:journal.1312225
43 schema:name Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).
44 schema:productId N0e49c9db1d8d400985c6d4445e020efd
45 N66f15c2644264b3da1f354d6cb8bd120
46 Nbfa423e959204d6ead89184efe4ac1e2
47 Nc45ec2333a2045b9ab1bf6aff4fd47f4
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113328033
49 https://doi.org/10.1007/s10147-019-01440-y
50 schema:sdDatePublished 2019-04-15T09:00
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher N7d19730e8df044eebb926503b18a06d7
53 schema:url http://link.springer.com/10.1007/s10147-019-01440-y
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N0121fa9eef9e4b1f82729314de119be3 rdf:first N21f80e7c223e4a06a495f2b644d24fcd
58 rdf:rest N388899b1b6d24555827a83c512ab7c67
59 N05be5ec319704c4fac20231751fbe683 rdf:first Nad219fcaf30547c2a2254dbb5bd579d1
60 rdf:rest N9f9606a6c0da4a319c68798a0cf79616
61 N0e49c9db1d8d400985c6d4445e020efd schema:name pubmed_id
62 schema:value 30968270
63 rdf:type schema:PropertyValue
64 N1f53b557a7824183aa8e526c06f48a40 schema:affiliation https://www.grid.ac/institutes/grid.482503.8
65 schema:familyName Yamamoto
66 schema:givenName Naoyoshi
67 rdf:type schema:Person
68 N21f80e7c223e4a06a495f2b644d24fcd schema:affiliation https://www.grid.ac/institutes/grid.413699.0
69 schema:familyName Okimoto
70 schema:givenName Tomoaki
71 rdf:type schema:Person
72 N388899b1b6d24555827a83c512ab7c67 rdf:first Na73416a474f74252bcc104565264040d
73 rdf:rest N45a2b7f3e6b34dbbbfbf569a86ebf7a0
74 N39bced3b4c424c02859d065679038aad rdf:first N72fdd04e4cf44118b06102aaa65c3666
75 rdf:rest N6075735ef4ff42bd8b2445aebe775582
76 N41ea47d70e134bf0a89bf727f3d40274 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
77 schema:familyName Ohno
78 schema:givenName Tatsuya
79 rdf:type schema:Person
80 N45a2b7f3e6b34dbbbfbf569a86ebf7a0 rdf:first N1f53b557a7824183aa8e526c06f48a40
81 rdf:rest N4b8ae7403f6f4b589a4708612ae7d7fc
82 N4b8ae7403f6f4b589a4708612ae7d7fc rdf:first Ndab53021ae6747a399dd7fca5f87ed5a
83 rdf:rest N05be5ec319704c4fac20231751fbe683
84 N6075735ef4ff42bd8b2445aebe775582 rdf:first N7578f298113a4d9280a38248a0951a88
85 rdf:rest Nadda8ad15eab43f589ea68cac25629cb
86 N66f15c2644264b3da1f354d6cb8bd120 schema:name nlm_unique_id
87 schema:value 9616295
88 rdf:type schema:PropertyValue
89 N72fdd04e4cf44118b06102aaa65c3666 schema:affiliation https://www.grid.ac/institutes/grid.482503.8
90 schema:familyName Tsuji
91 schema:givenName Hiroshi
92 rdf:type schema:Person
93 N7578f298113a4d9280a38248a0951a88 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
94 schema:familyName Nakano
95 schema:givenName Takashi
96 rdf:type schema:Person
97 N78b5221f0df148f6a0f521845a5f7b8e schema:affiliation https://www.grid.ac/institutes/grid.482503.8
98 schema:familyName Okonogi
99 schema:givenName Noriyuki
100 rdf:type schema:Person
101 N7d19730e8df044eebb926503b18a06d7 schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 N91c99a58db324e568e74a2a5227ce48f schema:name Ion Beam Therapy Center, SAGA HIMAT Foundation, Saga, Japan.
104 rdf:type schema:Organization
105 N9f9606a6c0da4a319c68798a0cf79616 rdf:first N41ea47d70e134bf0a89bf727f3d40274
106 rdf:rest Neede1ec6679348e784b2e9aa2d43e7f5
107 Na107e6679cc24214b246673044e29dfe schema:name Ion Beam Therapy Center, SAGA HIMAT Foundation, Saga, Japan.
108 rdf:type schema:Organization
109 Na73416a474f74252bcc104565264040d schema:affiliation Na107e6679cc24214b246673044e29dfe
110 schema:familyName Shinoto
111 schema:givenName Makoto
112 rdf:type schema:Person
113 Nad219fcaf30547c2a2254dbb5bd579d1 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
114 schema:familyName Murata
115 schema:givenName Kazutoshi
116 rdf:type schema:Person
117 Nad7a3633cbba47f79f842582ea6aeab0 rdf:first N78b5221f0df148f6a0f521845a5f7b8e
118 rdf:rest Nb46a22a0f78a47368936b341719b184e
119 Nadda8ad15eab43f589ea68cac25629cb rdf:first Nea8b9896fafb4a4eaa9fccd1a3ef0154
120 rdf:rest rdf:nil
121 Nb2850306c2d34344891e57afbb2477d7 schema:affiliation N91c99a58db324e568e74a2a5227ce48f
122 schema:familyName Shioyama
123 schema:givenName Yoshiyuki
124 rdf:type schema:Person
125 Nb46a22a0f78a47368936b341719b184e rdf:first Ne52fdfee18a94c9eb026d349a4e02786
126 rdf:rest N0121fa9eef9e4b1f82729314de119be3
127 Nbfa423e959204d6ead89184efe4ac1e2 schema:name doi
128 schema:value 10.1007/s10147-019-01440-y
129 rdf:type schema:PropertyValue
130 Nc45ec2333a2045b9ab1bf6aff4fd47f4 schema:name dimensions_id
131 schema:value pub.1113328033
132 rdf:type schema:PropertyValue
133 Ndab53021ae6747a399dd7fca5f87ed5a schema:affiliation https://www.grid.ac/institutes/grid.482503.8
134 schema:familyName Yamada
135 schema:givenName Shigeru
136 rdf:type schema:Person
137 Ne52fdfee18a94c9eb026d349a4e02786 schema:affiliation https://www.grid.ac/institutes/grid.256642.1
138 schema:familyName Kaminuma
139 schema:givenName Takuya
140 rdf:type schema:Person
141 Nea8b9896fafb4a4eaa9fccd1a3ef0154 schema:affiliation https://www.grid.ac/institutes/grid.482503.8
142 schema:familyName Kamada
143 schema:givenName Tadashi
144 rdf:type schema:Person
145 Neede1ec6679348e784b2e9aa2d43e7f5 rdf:first Nb2850306c2d34344891e57afbb2477d7
146 rdf:rest N39bced3b4c424c02859d065679038aad
147 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
148 schema:name Medical and Health Sciences
149 rdf:type schema:DefinedTerm
150 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
151 schema:name Oncology and Carcinogenesis
152 rdf:type schema:DefinedTerm
153 sg:journal.1312225 schema:issn 1341-9625
154 1437-7772
155 schema:name International Journal of Clinical Oncology
156 rdf:type schema:Periodical
157 sg:pub.10.1007/s12094-012-0956-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031392636
158 https://doi.org/10.1007/s12094-012-0956-2
159 rdf:type schema:CreativeWork
160 sg:pub.10.1007/s12094-015-1383-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1011357910
161 https://doi.org/10.1007/s12094-015-1383-y
162 rdf:type schema:CreativeWork
163 sg:pub.10.1186/1748-717x-8-79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026147741
164 https://doi.org/10.1186/1748-717x-8-79
165 rdf:type schema:CreativeWork
166 sg:pub.10.1186/s13014-017-0773-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083399651
167 https://doi.org/10.1186/s13014-017-0773-4
168 rdf:type schema:CreativeWork
169 sg:pub.10.1186/s13014-018-0969-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101003219
170 https://doi.org/10.1186/s13014-018-0969-2
171 rdf:type schema:CreativeWork
172 https://app.dimensions.ai/details/publication/pub.1078520481 schema:CreativeWork
173 https://doi.org/10.1002/bjs.4370 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027424378
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1002/cncr.26611 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052457938
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1002/jso.23058 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050595648
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1002/jso.24757 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090828743
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1016/j.clgc.2017.01.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016455692
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/j.ijrobp.2008.04.073 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007412870
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/j.ijrobp.2008.07.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050008070
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/j.ijrobp.2010.05.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042099654
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/j.ijrobp.2010.11.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033784149
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/j.ijrobp.2011.08.036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017514898
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/j.ijrobp.2011.09.053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038164386
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/j.ygyno.2017.12.028 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100240901
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1016/s0360-3016(98)00544-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026074608
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/s0959-8049(11)70142-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024474871
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1016/s1470-2045(12)70510-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020430700
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1088/0031-9155/60/8/3271 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059031274
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1093/jjco/hyn083 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039973595
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1093/jjco/hyp167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014598057
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1097/01.sla.0000160703.75808.7d schema:sameAs https://app.dimensions.ai/details/publication/pub.1052575937
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1097/jto.0b013e3182208e58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035497536
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1177/030089161109700110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078389831
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1177/1533034615595945 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016677093
216 rdf:type schema:CreativeWork
217 https://doi.org/10.18632/oncotarget.7636 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018716375
218 rdf:type schema:CreativeWork
219 https://doi.org/10.21873/anticanres.11991 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092116097
220 rdf:type schema:CreativeWork
221 https://doi.org/10.2307/3579446 schema:sameAs https://app.dimensions.ai/details/publication/pub.1070381843
222 rdf:type schema:CreativeWork
223 https://doi.org/10.3346/jkms.2009.24.3.488 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013182687
224 rdf:type schema:CreativeWork
225 https://www.grid.ac/institutes/grid.256642.1 schema:alternateName Gunma University
226 schema:name Department of Radiation Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
227 rdf:type schema:Organization
228 https://www.grid.ac/institutes/grid.413699.0 schema:alternateName Hyogo Medical Center
229 schema:name Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan.
230 rdf:type schema:Organization
231 https://www.grid.ac/institutes/grid.482503.8 schema:alternateName National Institutes for Quantum and Radiological Science and Technology
232 schema:name QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan.
233 QST Hospital, National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba, 263-8555, Japan. kamada.tadashi@qst.go.jp.
234 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...